Key result
Pt-CPT demonstrates superior antitumour efficacy over platinum-based drugs and camptothecin in ovarian cancer.
Why the study?
Platinum-based drugs and camptothecin improve efficacy and inhibit metastasis in ovarian cancer, but are limited by systemic toxicity, side effects, drug resistance, and dose-limiting toxicities.
A Pt(II)-camptothecin coordination complex shows promise for improved antitumour efficacy over single agents in ovarian cancer.
Answers are grounded in this paper and cite their sources.
Supports Pt-CPT development for ovarian cancer; hypothesis-generating and should not yet change practice.
Ovarian cancer (OC) has a high mortality rate for women. Except for those screening tools that help discover tumour cells, chemotherapy plays an indispensable role in treating ovarian cancer. Nowadays, an increasing number of anticancer drugs are developed, including synthetic and naturally extracted ones. Among these, platinum-based drug and camptothecin (CPT) are two typical anticancer agents commonly used in clinical area. They exhibit certain strengths in improving efficacy in tumour treatment and inhibiting metastasis. However, these two compounds show some common disadvantages, including systemic toxicity, side effects and drug resistance. Furthermore, the dose-limiting toxicity for cisplatin and leucopaenia of CPT, limit their antitumour performance. Hence, in this work, it makes comparisons between these two different drugs from mechanisms, common synthesis methods and targeted drug delivery systems. Additionally, a new and efficient compound, a Pt(II)-camptothecin coordination complex (Pt-CPT) is also discussed, which exhibits better antitumour ability than the two single drugs.
No takes yet. Share an insight, caveat, or question.
Yuhan Zhou (2025) studied this question. The Pt(II)-camptothecin coordination complex (Pt-CPT) demonstrated superior antitumour efficacy compared to both platinum-based drugs and camptothecin in ovarian cancer treatment.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: